BioSpace News Archive

Apollo Therapeutics, a biopharmaceutical company focused on translational biology and asset-centric drug development, and King’s College London, announced the formation of a new strategic collaboration.

Emergex Vaccines Holding Limited announces that it has been awarded a £490,525 grant by the UK government’s Department of Health and Social Care to advance a synthetic T cell vaccine candidate for Chikungunya virus.

Medivir AB announces that its new CEO Jens Lindberg will participate at the Erik Penser Bank Health Care Day, Thursday February 24, 2022.

Royal Philips, a global leader in health technology, published its Annual Report 2021.

Nordic Nanovector ASA announces that it will report its results for the fourth quarter and full year 2021 on Tuesday, 1 March 2022.

Semarion Ltd, a University of Cambridge spin-out company from the Cavendish Laboratory combining materials engineering and cell biology to tackle unmet drug screening needs, announced that it has closed a £2.14 million GBP seed funding round.

InfuSystem Holdings, Inc. announced a national distribution agreement with Solo-Dex, Inc. for its proprietary continuous nerve block catheters.

Mallinckrodt plc (OTCMKTS: MNKKQ), a global biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) regarding the Company’s New Drug Application (NDA) seeking approval for the investigational agent terlipressin to treat adults with hepatorenal syndrome.

ICON plc (NASDAQ:ICLR), a world-leading healthcare intelligence and clinical research organisation, today reported its financial results for the fourth quarter and full year ended December 31, 2021.

Amryt announces that it has secured $125 million of senior credit facilities from funds managed by the Credit Group of Ares Management Corporation (“Ares”).